1. Home
  2. XPL vs ICCC Comparison

XPL vs ICCC Comparison

Compare XPL & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.89

Market Cap

78.1M

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$8.01

Market Cap

64.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPL
ICCC
Founded
1984
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.1M
64.0M
IPO Year
2000
1995

Fundamental Metrics

Financial Performance
Metric
XPL
ICCC
Price
$0.89
$8.01
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.20
N/A
AVG Volume (30 Days)
177.9K
23.1K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
42.86
53.85
EPS
N/A
N/A
Revenue
N/A
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
51.64
52 Week Low
$0.54
$4.52
52 Week High
$0.98
$8.23

Technical Indicators

Market Signals
Indicator
XPL
ICCC
Relative Strength Index (RSI) 58.69 73.21
Support Level $0.70 $5.78
Resistance Level $0.98 N/A
Average True Range (ATR) 0.04 0.33
MACD 0.01 0.14
Stochastic Oscillator 75.61 87.88

Price Performance

Historical Comparison
XPL
ICCC

About XPL Solitario Resources Corp.

Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: